Year-over-year, this metric declined by 120.8%, from $7.26M to -$1.51M. Over 4 years (FY 2022 to FY 2026), Other Income (Expense) shows an upward trend with a 40.6% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | Q1 '27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.72M | $986.00K | $564.00K | $179.00K | $4.80M | $2.59M | $2.47M | $345.00K | $4.99M | $5.73M | $6.91M | $3.98M | $9.25M | $6.42M | $6.93M | $6.62M | $7.26M | $6.83M | $3.30M | $0.00 | -$1.51M |
| QoQ Change | — | -63.7% | -42.8% | -68.3% | >999% | -46.0% | -4.4% | -86.1% | >999% | +14.8% | +20.5% | -42.4% | +132.4% | -30.6% | +7.9% | -4.4% | +9.8% | -6.0% | -51.7% | -100.0% | — |
| YoY Change | — | — | — | — | +76.5% | +162.4% | +338.7% | +92.7% | +4.1% | +121.5% | +179.1% | >999% | +85.4% | +12.0% | +0.3% | +66.2% | -21.5% | +6.4% | -52.4% | -100.0% | -120.8% |